|
|
Volumn 116, Issue 9-10, 2004, Pages 339-345
|
|
The Austrian Society of Lung Diseases and Tuberculosis: Consensus on diagnosis and therapy of bronchial asthma in adult; revised version 2004;Österreichische Gesellschaft für Lungenerkrankungen und Tuberkulose: Konsensus zur diagnostik und therapie von asthma bei erwachsenen. Revidierte fassung 2004
a
a
b
c
c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CORTICOSTEROID;
FENOTEROL;
FORMOTEROL;
IPRATROPIUM BROMIDE;
SALBUTAMOL;
SALMETEROL;
TERBUTALINE;
ANTIASTHMATIC AGENT;
ANTIINFLAMMATORY AGENT;
ASTHMA;
AUSTRIA;
CONSENSUS;
DIFFERENTIAL DIAGNOSIS;
HUMAN;
INHALATION TEST;
LUNG FUNCTION TEST;
MEDICAL SOCIETY;
PATHOPHYSIOLOGY;
PEAK EXPIRATORY FLOW;
RISK FACTOR;
SHORT SURVEY;
ADULT;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONFERENCE PAPER;
CONSENSUS DEVELOPMENT;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
EVIDENCE BASED MEDICINE;
FORCED EXPIRATORY VOLUME;
INHALATIONAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
ADMINISTRATION, INHALATION;
ADRENAL CORTEX HORMONES;
ADULT;
ANTI-ASTHMATIC AGENTS;
ANTI-INFLAMMATORY AGENTS;
ASTHMA;
BRONCHODILATOR AGENTS;
EVIDENCE-BASED MEDICINE;
FORCED EXPIRATORY VOLUME;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
TREATMENT OUTCOME;
|
|
EID: 3042643323
PISSN: 00435325
EISSN: None
Source Type: Journal
DOI: 10.1007/bf03040907 Document Type: Short Survey |
|
Times cited : (2)
|
|
References (4)
|
